Glycemic control after addition of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes showing inadequate response to thrice-a-day treatment with α-glucosidase inhibitors
Masuda, Kiyomi, Aoki, Kazutaka, Kamiko, Kazunari, Takihata, Masahiro, Ito, Yuzuru, Nagakura, Mieko, Kawasaki, Satsuki, Akema, Noriko, Hasegawa, Maki, Nakajima, Shigeru, Shinoda, Kazuaki, Toumura, ShyoVolume:
14
Language:
english
Journal:
Expert Opinion on Pharmacotherapy
DOI:
10.1517/14656566.2013.790365
Date:
June, 2013
File:
PDF, 560 KB
english, 2013